10.12.2011 [PharmiWeb.com (press release)] - Incorporated acted as sole book-running manager in the offering and WilliamBlair & Company, LLC acted as co-manager for the offering. A copy of the final prospectus related to the offering may be obtained by contacting: Robert W. Baird & Co.
06.12.2011 [Proactive Investors UK] - ... Price target is USD 36 General Electric – Co. upgraded to Outperform from Market Perform at Bernstein, Price target raised to USD 21 from USD 19 MetroPCS – Co. upgraded to Outperform from Market Perform at WilliamBlair Lorillard – Co. price target
06.12.2011 [PharmiWeb.com (press release)] - Incorporated is acting as sole book-running manager in the offering and WilliamBlair & Company, LLC is acting as co-manager for the offering. Exact has granted the underwriters a 30-day option to purchase up to an aggregate of 468750 additional shares
22.11.2011 [OutSourcing-Pharma.com] - That is the view of Gareth Down, head of European Healthcare at WilliamBlair International, who shared his - generally upbeat - analysis of the contract research market with delegates at Partnerships in Clinical Trials (PCT) Congress in Lyon
22.11.2011 [OutSourcing-Pharma.com] - However, top-line growth was impressive and revenue and gross margin guidance for 2011 was reconfirmed”, Liping Cai, equity analyst at WilliamBlair, wrote in a note to investors. Hui said “rapid utilisation” at the new site will add to sales in 2012.